文献速递心血管MR

心脏磁共振在评估瓣膜性心脏病中的应用:诊断、严重程度与结局

CMR in Evaluating Valvular Heart Disease: Diagnosis, Severity, and Outcomes.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-11-25

该综述阐述心脏磁共振(CMR)可评估全部4个心脏瓣膜,具有自由选择成像平面、准确血流和容积定量等优势,能分别评估多瓣膜病变且不受血流动力学状态影响;对反流性病变的准确定量及心肌改变的表征有助于预测无症状患者的临床结局。文章介绍了主要CMR方法、优缺点及评估瓣膜病变的最佳应用方式,以补充超声心动图并优化患者评估。

要点

  • CMR可评估全部4个心脏瓣膜,自由选择成像平面并准确量化血流与容积。
  • CMR可分别评估多瓣膜病变中的每个瓣膜,且不受血流动力学状态影响。
  • 反流性病变的准确定量及心肌改变表征有助于预测无症状患者的临床结局。

核心结论

  • CMR可补充超声心动图用于心脏瓣膜病评估,并增强患者评估。

研究设计与样本

  • 综述,未报告检索范围与纳入文献数量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiac magnetic resonance (CMR) is a versatile imaging tool that brings much to the assessment of valvular heart disease. Although it is best known for myocardial imaging (even in valve disease), it provides excellent assessment of all 4 heart valves, with some distinct advantages, including a free choice of image planes and accurate flow and volumetric quantification. These allow the severity of each valve lesion to be characterized, in addition to optimal visualization of the surrounding outflow tracts and vessels, to deliver a comprehensive package. It can assess each valve lesion separately (in multiple valve disease) and is not affected by hemodynamic status. The accurate quantitation of regurgitant lesions and the ability to characterize myocardial changes also provides an ability to predict future clinical outcomes in asymptomatic patients. This review outlines how CMR can be used in cardiac valve disease to compliment echocardiography and enhance the patient assessment. It covers the main CMR methods used, their strengths and limitations, and the optimal way to apply them to evaluate valve disease.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Myerson SG. CMR in Evaluating Valvular Heart Disease: Diagnosis, Severity, and Outcomes. JACC Cardiovasc Imaging. 2020. PMID: 33248967. doi:10.1016/j.jcmg.2020.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。